ElectroCore announced this week that Chief Financial Officer Brian Posner will be retiring on October 4. In conjunction with his retirement, the vagus nerve stimulator company announced it promoted Chief Strategy Officer Joshua Lev to the CFO role, effective as of Posner’s retirement. Lev has been with the company since February 2020, when he was […]
electroCore
ElectroCore expands nerve stimulation IP portfolio
ElectroCore (Nasdaq:ECOR) announced today that the U.S. Patent and Trademark office (USPTO) issued it a new nerve stimulation patent. The new patent (No. 11,839,764 ) relates to a system for stimulating a nerve target in the head or neck of a patient. It covers the treatment of various disorders, such as primary headache. It’s titled […]
ElectroCore expands patent portfolio for non-invasive vagus nerve stimulation tech
ElectroCore (Nasdaq:ECOR) announced today that it received patent issue notifications from the USPTO for three new patents. All three — issued on April 11 — relate to ElectroCore’s non-invasive vagus nerve stimulation (nVNS) technology. Rockaway, New Jersey-based ElectroCore received U.S. patents Nos. 11,623,078, 11,623,079 and 11,623,080. The first (11,623,078) is titled “Devices and Methods for […]
ElectroCore lands EUA for COVID-19 vagus nerve stim use
ElectroCore this week said it received FDA emergency use authorization for its gammaCore Sapphire CV to treat asthma exacerbations in known or suspected COVID-19 patients. The gammaCore Sapphire CV is a non-invasive vagus nerve stimulation that can be used at home or in a healthcare setting to acutely treat adults with known or suspected COVID-19 […]
ElectroCore selling up to $25m in stock to Lincoln Park
ElectroCore (NSDQ:ECOR) announced today that it entered into a purchase agreement in which the neuroscience company has the right to sell shares of its common stock worth up to $25 million to Lincoln Park Capital Fund. Basking Ridge, N.J.-based ElectroCore would control the timing and amount of any sales of its common stock, valued at $0.001 […]
Nelipak names Roger Prevot CEO | Personnel Moves, Oct. 16, 2019
Nelipak Corp. said last week that Roger Prevot will take over as CEO, following the retirement of current CEO Michael Kelly. Kelly was in charge when private equity giant Kohlberg bought Nelipak for an undisclosed amount July 2. Kelly is retiring after overseeing the deal and positioning the company for the next phase of its […]
ElectroCore plunges after FDA asks for more GammaCore data
ElectroCore (NSDQ:ECOR) shares plunged today after the company said the FDA asked for more data on a bid for an expanded indication for its GammaCore device. Basking Ridge, N.J.-based ElectroCore asked for an expanded 510(k) indication covering prevention of migraine with ElectroCore, a non-invasive vagus nerve stimulator. Today the company said the federal safety watchdog asked […]
Tevosol taps Organ Recovery Systems vet Mills for CEO | Personnel Moves, June 17, 2019
Tevosol said it named Organ Recovery Systems veteran Ron Mills to be its new CEO. “Ron knows our technology and our market,” co-founder & CSO Dr. Darren Freed said in prepared remarks. “He brings a wealth of relevant experience to our team and adds a spark of creativity to drive the next exciting stage of […]
Conventus Ortho taps Epstein as CEO | Personnel Moves – June 5, 2019
Conventus Orthopaedics said today that it named Rick Epstein as its new chief executive officer and board member. The Minneapolis-based company said that Epstein has more than 30 years in executive leadership roles, having previously served as chief executive officer for Omni Life Sciences. “Rick has a track record of accelerating businesses through a focus […]
ElectroCore announces workforce reductions, resource adjustments
ElectroCore said yesterday that it’s planning to cut nearly 40% from its workforce and “resource adjustments” as it looks to focus on “currently available and near-term revenue opportunities and on clinical programs specifically designed to expand the GammaCore product labeling.” The layoffs affect the Basking Ridge, N.J.-based company’s field sales force and clinical operations. ElectroCore […]
Nevro taps ex-Thoratec CEO Grossman | Personnel Moves, March 20, 2019
Nevro Corp. (NYSE:NVRO) said yesterday that it named former Thoratec CEO Keith Grossman to replace president & CEO Rami Elghandour after striking a deal with one of its investors, Broadfin Capital. Grossman re-joined Thoratec after taking over at Conceptus in December 2011 and leading it to a $1.1 billion sale to Bayer in June 2013 (he’d […]
